Alessandro Noseda
Director/Miembro de la Junta en REGENERX BIOPHARMACEUTICALS, INC. .
Fortuna: - $ al 31/03/2024
Perfil
Alessandro Noseda is an Independent Director at RegeneRx Biopharmaceuticals, Inc. He is also a Director at Metheresis Translational Research SA, Thule Therapeutics SA, and Rostaquo.
Previously, he served as the Chief Medical Officer at Leadiant Biosciences, Inc. from 1998 to the present.
He also held the position of Chief Scientific Officer at Leadiant Biosciences SpA from 2007 to the present.
Prior to that, he was the Chief Executive Officer at Leadiant Biosciences SA from 2007 to 2017.
Dr. Noseda holds a doctorate degree from Wake Forest School of Medicine and the University of Milan, which he received in 1984.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Alessandro Noseda
| Empresas | Cargo | Inicio |
|---|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/04/2019 |
Leadiant Biosciences SpA
 Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | Director Técnico/Científico/I+D | 01/01/2014 |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Director Técnico/Científico/I+D | 01/09/2018 |
| Thule Therapeutics SA | Director/Miembro de la Junta | - |
| Rostaquo | Director/Miembro de la Junta | - |
| Metheresis Translational Research SA | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Alessandro Noseda.
| Empresas | Cargo | Fin |
|---|---|---|
Leadiant Biosciences SA
 Leadiant Biosciences SA Miscellaneous Commercial ServicesCommercial Services Leadiant Biosciences SA conducts biotechnological research. | Director Ejecutivo | 01/01/2017 |
Formación de Alessandro Noseda.
| University of Milan | Doctorate Degree |
| Wake Forest School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
Leadiant Biosciences SpA
Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | Health Technology |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Health Technology |
Leadiant Biosciences SA
Leadiant Biosciences SA Miscellaneous Commercial ServicesCommercial Services Leadiant Biosciences SA conducts biotechnological research. | Commercial Services |
| Thule Therapeutics SA | |
| Rostaquo | |
| Metheresis Translational Research SA |
- Bolsa de valores
- Insiders
- Alessandro Noseda
